Patterns within protein/polyphosphoinositide interactions provide specific targets for therapeutic intervention

被引:20
作者
Berrie, CP
Falasca, M
机构
[1] Ist Ric Farmacol Mario Negri, Consorzio Mario Negri Sud, Dept Cell Biol & Oncol, I-66030 Santa Maria Imbaro, Chieti, Italy
[2] Univ G DAnnunzio, Sch Med, Dept Oncol & Neurosci, Sect Med Oncol, I-66100 Chieti, Italy
关键词
phosphoinositide; 3-kinase; polyphosphoinositides; inositol polyphosphates; PH/FYVE/HIKE domains; cancer therapy;
D O I
10.1096/fj.00-0096hyp
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Signaling pathways involving the inositol polyphosphates and the polyphosphoinositides have become intricately linked with a number of disease states. More recently, this has principally involved the 3-phosphorylated products of phosphoinositide S-kinase, an enzyme that itself shows oncogenic activity and has hence become of interest in the design of antitumorigenic drugs. The downstream effecters of phosphoinositide 3-kinase are involved in different aspects of cellular signaling and cytoskeleton and trafficking events that are linked to specific polyphosphoinositide binding properties of specific protein domains, which themselves have emerging roles in specific disease states. Our recent findings have demonstrated that there is a selectivity of the intracellular effects of extracellularly applied inositol polyphosphates in their abilities to inhibit a range of growth-related in vivo assay conditions, and that these can themselves be linked to the inhibition of the membrane localization of a green fluorescent protein (GFP) -tagged PH domain. We propose that GFP fusions of the polyphosphoinositides binding domains of specific proteins of interest can be used in high-throughput investigations of the therapeutic value of specific inositol polyphosphates analogs. Inhibition of in vivo membrane targeting of these domains from proteins involved in cell growth and tumorigenesis can thus be used in the search for new anticancer drugs.
引用
收藏
页码:2618 / 2622
页数:5
相关论文
共 43 条
[1]  
Alberti S, 1998, PROTEINS, V31, P1, DOI 10.1002/(SICI)1097-0134(19980401)31:1<1::AID-PROT1>3.0.CO
[2]  
2-R
[3]  
[Anonymous], OMIM ONLINE MENDELIA
[4]   PTEN/MMAC1/TEP1 in signal transduction and tumorigenesis [J].
Besson, A ;
Robbins, SM ;
Yong, VW .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1999, 263 (03) :605-611
[5]   Lithium activates the serine/threonine kinase Akt-1 and suppresses glutamate-induced inhibition of Akt-1 activity in neurons [J].
Chalecka-Franaszek, E ;
Chuang, DM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (15) :8745-8750
[6]   Large and diverse numbers of human diseases with HIKE mutations [J].
Ciccarelli, FD ;
Acciarito, A ;
Alberti, S .
HUMAN MOLECULAR GENETICS, 2000, 9 (06) :1001-1007
[7]   Phosphoinositides in membrane traffic [J].
Corvera, S ;
D'Arrigo, A ;
Stenmark, H .
CURRENT OPINION IN CELL BIOLOGY, 1999, 11 (04) :460-465
[8]  
Dong ZG, 1999, ANTICANCER RES, V19, P3743
[9]   D-myo-inositol 1,4,5,6-tetrakisphosphate produced in human intestinal epithelial cells in response to Salmonella invasion inhibits phosphoinositide 3-kinase signaling pathways [J].
Eckmann, L ;
Rudolf, MT ;
Ptasznik, A ;
Schultz, C ;
Jiang, T ;
Wolfson, N ;
Tsien, R ;
Fierer, J ;
Shears, SB ;
Kagnoff, MF ;
Traynor-Kaplan, AE .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (26) :14456-14460
[10]   PRIMING ACTION OF INOSITOL HEXAKISPHOSPHATE (INSP6) ON THE STIMULATED RESPIRATORY BURST IN HUMAN NEUTROPHILS [J].
EGGLETON, P ;
PENHALLOW, J ;
CRAWFORD, N .
BIOCHIMICA ET BIOPHYSICA ACTA, 1991, 1094 (03) :309-316